• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Drug therapy of pulmonary and portal hypertension in liver cirrhosis].

作者信息

Vorob'ev L P, Maev I V, Andreev N G

出版信息

Klin Med (Mosk). 1991 Feb;69(2):64-7.

PMID:1875666
Abstract

Detailed examination of hemodynamics in patients with portal and pulmonary hypertension was performed upon acute drug tests and course administration of nitrosorbide++, corinfar and propranolol. Ultrasound and rheography investigations were employed to elucidate the relations between portal and pulmonary hypertension in cirrhosis patients. Criteria of early diagnosis are discussed. Nitrosorbide++ produced positive effect on hepatic blood flow, corinfar improved pulmonary hemodynamics in lack of its influence on hepatic blood flow, while propranolol resulted in the drop of both portal and pulmonary hypertension, normalization of general hemodynamics.

摘要

相似文献

1
[Drug therapy of pulmonary and portal hypertension in liver cirrhosis].
Klin Med (Mosk). 1991 Feb;69(2):64-7.
2
[The effect of nitrosorbide, korinfar and obzidan on the hemodynamics of patients with chronic hepatitis and liver cirrhosis based on the data acute drug trials].基于急性药物试验数据探讨亚硝基异山梨酯、科莫非尔和奥布齐丹对慢性肝炎和肝硬化患者血流动力学的影响
Farmakol Toksikol. 1991 Sep-Oct;54(5):54-7.
3
[Propranolol and 5-isosorbide mononitrate in patients with cirrhosis: systemic and portal hemodynamic events].[心得安与5-单硝酸异山梨酯用于肝硬化患者:全身及门静脉血流动力学变化]
Gastroenterol Hepatol. 2000 Jun-Jul;23(6):275-81.
4
Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis.门静脉高压症药物治疗的血流动力学反应及肝硬化的长期预后
Hepatology. 2003 Apr;37(4):902-8. doi: 10.1053/jhep.2003.50133.
5
[New trends in the treatment of hemodynamic disorders in liver cirrhosis].[肝硬化血流动力学紊乱治疗的新趋势]
Klin Med (Mosk). 1991 Sep;69(9):11-4.
6
Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects.普萘洛尔与普萘洛尔加硝酸异山梨酯用于门静脉高压患者的比较:长期血流动力学和肾脏效应
Hepatology. 1993 Sep;18(3):477-84.
7
Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis.在降低病毒性肝硬化患者门静脉压力方面,卡维地洛急性给药比普萘洛尔加5-单硝酸异山梨酯更有效。
Am J Gastroenterol. 2004 Oct;99(10):1953-8. doi: 10.1111/j.1572-0241.2004.40179.x.
8
[The use of anaprilin for the correction of portal hypertension in liver cirrhosis].
Vrach Delo. 1989 Nov(11):19-22.
9
Long term effects of propranolol on portal pressure in cirrhotic patients.普萘洛尔对肝硬化患者门静脉压力的长期影响。
Rom J Gastroenterol. 2003 Mar;12(1):25-30.
10
Rapid normalization of portopulmonary hypertension after living donor liver transplantation.活体肝移植术后门肺高压快速恢复正常
Transplant Proc. 2009 Jun;41(5):1976-8. doi: 10.1016/j.transproceed.2009.02.095.